← FDA DRUG APPROVALS

FDA ANDA · ANDA090759

FLUTICASONE PROPIONATE

Sponsor: GLENMARK PHARMS LTD

APPLICATION
ANDA090759
TYPE
ANDA
ORIGINAL APPROVAL
2011-05-02
LATEST ACTION
2019-11-14
ROUTE
TOPICAL
DOSAGE FORM
LOTION
MARKETING STATUS
Discontinued

Products

FLUTICASONE PROPIONATEDiscontinued
FLUTICASONE PROPIONATE 0.05% · LOTION · TOPICAL

Approval history

2019-11-14Labeling · Supplement 5 · standardAP
2019-11-14Labeling · Supplement 3 · standardAP
2011-12-08Labeling · Supplement 1AP
2011-05-02OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →